Chronic Diseases and Telemedicine

Burak ÖZBAŞa

aDr. Abdurrahman Yurtaslan Oncology Research and Training Hospital, Clinic of Endocrinology and Metabolic Diseases, Ankara, Türkiye

ABSTRACT
The increasing population and the pandemic conditions that have emerged in recent years have forced countries to use telemedicine applications more actively and intensively. It is known that telemedicine can be used for many different chronic diseases. Telemedicine provides excellent convenience to patients and allows governments to reduce costs. Despite these positive aspects, telemedicine is not precisely where it should be, and there is a path to be taken due to reasons such as patients not being able to adapt to technology, not being able to appeal to different ethnic structures, doctors not being welcoming enough and not having enough infrastructure.
Keywords: Telemedicine; chronic diseases; cost of illness; COVID-19

Referanslar

  1. Kelly JT, Reidlinger DP, Hoffmann TC, Campbell KL. Telehealth methods to deliver dietary interventions in adults with chronic disease: a systematic review and meta-analysis. Am J Clin Nutr. 2016;104(6):1693-702. [Crossref]  [PubMed]
  2. Hailey D, Roine R, Ohinmaa A. Systematic review of evidence for the benefits of telemedicine. J Telemed Telecare. 2002;8 Suppl 1:1-30. [Crossref]  [PubMed]
  3. Snoswell CL, Chelberg G, De Guzman KR, Haydon HH, Thomas EE, Caffery LJ, ET AL. The clinical effectiveness of telehealth: A systematic review of meta-analyses from 2010 to 2019. J Telemed Telecare. 2023;29(9):669-84. [Crossref]  [PubMed]
  4. Harky A, Chiu CM, Yau THL, Lai SHD. Cancer Patient Care during COVID-19. Cancer Cell. 2020;37(6):749-50. [Crossref]  [PubMed]  [PMC]
  5. Snoswell CL, Taylor ML, Comans TA, Smith AC, Gray LC, Caffery LJ. Determining if Telehealth Can Reduce Health System Costs: Scoping Review. J Med Internet Res. 2020;22(10):e17298. [Crossref]  [PubMed]  [PMC]
  6. He T, Liu X, Li Y, Wu Q, Liu M, Yuan H. Remote home management for chronic kidney disease: A systematic review. J Telemed Telecare. 2017;23(1):3-13. [Crossref]  [PubMed]
  7. Stevenson JK, Campbell ZC, Webster AC, Chow CK, Tong A, Craig JC, et al. eHealth interventions for people with chronic kidney disease. Cochrane Database Syst Rev. 2019;8(8):CD012379. [Crossref]  [PubMed]  [PMC]
  8. Baratloo A, Rahimpour L, Abushouk AI, Safari S, Lee CW, Abdalvand A. Effects of Telestroke on Thrombolysis Times and Outcomes: A Meta-analysis. Prehosp Emerg Care. 2018;22(4):472-84. [Crossref]  [PubMed]
  9. Tchero H, Tabue Teguo M, Lannuzel A, Rusch E. Telerehabilitation for Stroke Survivors: Systematic Review and Meta-Analysis. J Med Internet Res. 2018;20(10):e10867. [Crossref]  [PubMed]  [PMC]
  10. Chongmelaxme B, Lee S, Dhippayom T, Saokaew S, Chaiyakunapruk N, Dilokthornsakul P. The Effects of Telemedicine on Asthma Control and Patients' Quality of Life in Adults: A Systematic Review and Meta-analysis. J Allergy Clin Immunol Pract. 2019;7(1):199-216.e11. [Crossref]  [PubMed]
  11. Kamei T, Yamamoto Y, Kajii F, Nakayama Y, Kawakami C. Systematic review and meta-analysis of studies involving telehome monitoring-based telenursing for patients with chronic obstructive pulmonary disease. Jpn J Nurs Sci. 2013;10(2):180-92. [Crossref]  [PubMed]
  12. Hazin R, Qaddoumi I. Teleoncology: current and future applications for improving cancer care globally. Lancet Oncol. 2010;11(2):204-10. [Crossref]  [PubMed]
  13. Shirke MM, Shaikh SA, Harky A. Implications of Telemedicine in Oncology during the COVID-19 Pandemic. Acta Biomed. 2020;91(3):e2020022.